ZTS: SEC Form 10-Q filed by Zoetis Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for ZTS
Across the 3 sessions after earlier ZTS headlines, the stock closed higher 0 times and lower 3 times, with a median move of 1.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | ZTS | SPY |
|---|---|---|---|
| Nov 4, 2025 | Zoetis Announces Third Quarter 2025 Resultsand 1 other headline that session | -13.8% | -1.2% |
| Oct 29, 2025 | Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats | -1.0% | +0.0% |
| Oct 28, 2025 | Zoetis Appoints Stephanie Tilenius to its Board of Directors | -1.4% | +0.3% |
Quantisnow market dataNYSE
ZTS
Zoetis Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2013
Get push alerts for ZTS
Full ZTS profile on Quantisnow Follow ZTS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time